Psychiatry & Neurology, Addiction Medicine · Guaynabo, PR
NPI
1851420004
Since 2007
Specialty
Psychiatry & Neurology, Addiction Medicine
Code 2084A0401X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
Edif Caparra Gallery, Ave. Gonzales Giusti No. 170 Suite 300
Guaynabo, PR, 00966
Phone (787) 531-6840
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$69K
7,408 prescriptions
Company payments
-
None reported
Medicare prescription drug claims, 2024
In 2024, the drug Manuel A Diaz prescribed most often to Medicare patients was Clonazepam, with 1,148 prescriptions and refills. In total Manuel A Diaz wrote 7,408 Medicare prescriptions that cost $69K.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2007-07-08.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Clonazepam Generic | 1,148 | 1,148 | 132 | $3,833 |
| Trazodone Hcl Generic | 787 | 793 | 79 | $4,958 |
| Temazepam Generic | 761 | 761 | 98 | $2,600 |
| Sertraline Hcl Generic | 631 | 635 | 69 | $3,319 |
| Fluoxetine Hcl Generic | 482 | 484 | 52 | $2,311 |
| Risperidone Generic | 344 | 344 | 37 | $1,892 |
| Lorazepam Generic | 311 | 311 | 43 | $880 |
| Buspirone Hcl Generic | 265 | 265 | 33 | $1,150 |
| Bupropion Xl Bupropion Hcl | 224 | 228 | 23 | $3,784 |
| Citalopram Hbr Citalopram Hydrobromide | 213 | 213 | 24 | $831 |
| Quetiapine Fumarate Generic | 203 | 203 | 22 | $1,207 |
| Escitalopram Oxalate Generic | 198 | 198 | 21 | $1,184 |
| Alprazolam Generic | 184 | 184 | 21 | $469 |
| Zolpidem Tartrate Generic | 158 | 158 | 19 | $443 |
| Estazolam Generic | 144 | 144 | 19 | $2,236 |
Brand drugs: 66 claims; generic drugs: 7,342 claims.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Manuel A Diaz were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.